christophe weber takeda

Takeda, Christophe Weber

Drugmaker Takeda's CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook. Julie Kim,

STAT · 22h

Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price over the last couple of years.

MM&M · 18h

Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed him

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S. business unit.

14hon MSN

Takeda signals 2025 growth with raised guidance, JPY 100B buyback, and new leadership transition

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Management View Christophe Weber, CEO, announced his retirement ...

20h

Takeda picks first woman as CEO of centuries-old drugmaker

Julie Kim has been running Takeda’s US operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval.

Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed

Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.

Hosted on MSN2d

Embracing AI is necessary for legacy industries, leaders say

A commitment to embracing AI and the changing digital world are key to success in legacy industries, Bank of America CEO Brian Moynihan and Takeda Pharmaceutical CEO Christophe Weber said. Why it ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results